Women with metastatic breast cancer can receive bisphosphonates less frequently and s

[News]

Women with metastatic breast cancer to the bone may be able to receive bisphosphonates, the bone-targeting class of drugs like zoledronic acid, less often after the first year of monthly administration.

More... (http://www.news-medical.net/news/20140531/Women-with-metastatic-breast-cancer-can-receive-bisphosphonates-less-frequently-and-safely.aspx)